Cost and cost-effectiveness of attractive targeted sugar baits (ATSB) in the context of a phase III cluster randomized control trial in Western Province, Zambia
ATSB Sarabi v.1.2 as deployed in western Zambia were not likely to be cost -effective. ATSB would need to demonstrate higher or more certain efficacy along with affordable alternative distribution strategies prior to any deployment at scale. Trial registration The trial is registered on clinicaltrials.gov under registration number: NCT04800055.
Authors
- Joseph Wagman (ORCID: https://orcid.org/0000-0002-5178-3098)
- Kafula Silumbe
- Joshua Yukich (ORCID: https://orcid.org/0000-0002-6160-5295)
- Kochelani Saili (ORCID: https://orcid.org/0000-0002-1432-1126)
- Busiku Hamainza (ORCID: https://orcid.org/0000-0001-7204-1555)
- Ruth A. Ashton (ORCID: https://orcid.org/0000-0002-7248-7730)
- Erica Orange
- Thomas P. Eisele (ORCID: https://orcid.org/0000-0002-2205-622X)
- John M. Miller (ORCID: https://orcid.org/0000-0002-1655-9621)
- Laurence Slutsker
- Javan Chanda
- Brooke Mancuso
- Megan Littrell
- S. Assefa
- Mulenga Matches
Institutions
- Tulane University (US)
- Program for Appropriate Technology in Health (US)
- AID Atlanta (US)
- National HIV/AIDS/STI/TB Council (ZM)
Publication Details
- Journal
- Malaria Journal
- Published
- 2025-12-19
- DOI
- https://doi.org/10.1186/s12936-025-05716-9
- Primary Topic
- Diabetes Management and Education
- Type
- article
- Field-Weighted Citation Impact
- 0.00